Sharon Stone partners with Galderma in Restylane campaign

Actress Sharon Stone has partnered with Galderma to launch an international campaign on Restylane products, including a “proof in real life” event in Berlin, in which treatments were compared in identical twins.

“It’s been a fascinating experience to follow the twins’ journeys and be with them tonight as they showcase the results in real life,” Stone said in a Galderma press release. “So many people are put off aesthetic treatments because of extreme images, and the Proof in Real Life campaign has provided results people have been able to see first-hand, giving them an opportunity to judge for themselves.”

Sharon Stone

Stone is the first celebrity to endorse an aesthetic brand, according to the release.

Ten sets of identical twins took part in the campaign, in which one twin from each pair received treatment consisting of Restylane (hyaluronic acid) fillers, Restylane Skinboosters, or both, the release stated. The twins then took part in the reveal in Berlin.

“I had never considered facial fillers and I was a bit worried they would dramatically alter my face,” participant James Martin, aged 37, who received Restylane filler treatments, said in the release. “The results were subtle but made such a difference.”

All the untreated twins are now considering treatment, according to the release.

The campaign is being promoted in Europe, the Middle East and Africa, Latin America and the Asian-Pacific. It is not being activated in the United States, according to the release.

Restylane filler treatments are used to reduce lines, folds and wrinkles and create fuller lips, enhancing contours and facial volume, and can last up to 12 months, according to the release. Restylane Skinboosters deliver lasting miniaturization to improve skin quality, hydration, elasticity and firmness of the face, neck, hands and décolletage, the release stated.

“The aim of this campaign is to break down the current misconceptions of aesthetic treatments and show the subtle and natural looking results,” Anne-Sophie Copin, global head of Skin Rejuvenation and Aesthetics and Corrective at Galderma, said in the release.

Reference: www.galderma.com